For sake of argument lets say ..

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

For sake of argument lets say ..

posted on May 31, 2022 11:06AM

Don has actually been in negotiations with Pharma for a couple years or so now & after all this time one of the many BP's working with them have decided its time to buy us out, would or should we see a significant jump in our SP on this OTC expert market leading up to this kind of significant news event?

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply